2017
DOI: 10.12688/f1000research.11775.1
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study

Abstract: Background: Chronic telogen effluvium (CTE) may be primary or secondary to various causes, including drug reaction, nutritional deficiency and female pattern hair loss (FPHL).  Oral minoxidil stimulates hair growth, and topical minoxidil is used in the treatment of FPHL and male androgenetic alopecia. minoxidil has not been used to treat CTE. This study aimed to assess the treatment of CTE with once daily oral minoxidil. Methods: Women with a diagnosis of CTE based on >6 month history of increased telogen hair… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
46
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(49 citation statements)
references
References 18 publications
0
46
0
3
Order By: Relevance
“…Nine studies [4][5][6]8,[12][13][14][15][16] used OM in monotherapy in 140 patients (31.7%), whereas five studies 7,[9][10][11]17 used OM in monotherapy or as an additional treatment in 302 patients (68.3%). Doses of oral minoxidil ranged between 0.25 and 5 mg.…”
Section: Treated Conditions and Oral Minoxidil Regimenmentioning
confidence: 99%
See 1 more Smart Citation
“…Nine studies [4][5][6]8,[12][13][14][15][16] used OM in monotherapy in 140 patients (31.7%), whereas five studies 7,[9][10][11]17 used OM in monotherapy or as an additional treatment in 302 patients (68.3%). Doses of oral minoxidil ranged between 0.25 and 5 mg.…”
Section: Treated Conditions and Oral Minoxidil Regimenmentioning
confidence: 99%
“…Three of them reported no variation of mean BP, whereas three studies reported a slight reduction in systolic BP and diastolic BP. 6,7,12 Three studies reported postural hypotension or dizziness in a total of five patients (1.1%). 7,8,12 Interestingly, this AE occurred only in women and with low doses of OM, namely 0.25 mg (three patients),…”
Section: Blood Pressure Variationmentioning
confidence: 99%
“…Recent studies have investigated the efficacy of low-dose oral minoxidil (0. effluvium, and monilethrix, with promising results shown including increased hair thickness in LPP. [65][66][67][68] Although no studies have been published to date on the efficacy of oral minoxidil for FFA, it is nevertheless a potential consideration for adjunctive therapy, particularly if the FFA is unmasking androgenetic alopecia. Future studies are needed to investigate the efficacy of oral minoxidil specifically for patients with FFA.…”
Section: Oral Minoxidilmentioning
confidence: 99%
“…3,4 In dermatology, topical minoxidil (TMX) has been used off-label for several types of alopecia, including telogen effluvium, alopecia areata (AA), eyebrow hypotrichosis, hair shaft disorders, chemotherapy-induced alopecia (CIA), traction alopecia (TA), and scarring alopecias. 5,6 TMX is not FDA-approved in patients under 18 years old and there are no guidelines for its pediatric use. 7 Many studies have been conducted linking TMX and hair regrowth in adults.…”
Section: Introductionmentioning
confidence: 99%